Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.78
CAH's Cash to Debt is ranked higher than
60% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.78 vs. CAH: 0.78 )
CAH' s 10-Year Cash to Debt Range
Min: 0.01   Max: 1.29
Current: 0.78

0.01
1.29
Equity to Asset 0.26
CAH's Equity to Asset is ranked lower than
54% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.37 vs. CAH: 0.26 )
CAH' s 10-Year Equity to Asset Range
Min: 0.23   Max: 0.43
Current: 0.26

0.23
0.43
F-Score: 5
Z-Score: 5.15
M-Score: -3.21
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) 0.99
CAH's Operating margin (%) is ranked lower than
59% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.78 vs. CAH: 0.99 )
CAH' s 10-Year Operating margin (%) Range
Min: 0.99   Max: 4.15
Current: 0.99

0.99
4.15
Net-margin (%) 0.33
CAH's Net-margin (%) is ranked lower than
61% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.80 vs. CAH: 0.33 )
CAH' s 10-Year Net-margin (%) Range
Min: 0.33   Max: 2.42
Current: 0.33

0.33
2.42
ROE (%) 5.59
CAH's ROE (%) is ranked lower than
56% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.25 vs. CAH: 5.59 )
CAH' s 10-Year ROE (%) Range
Min: 5.59   Max: 26.18
Current: 5.59

5.59
26.18
ROA (%) 1.29
CAH's ROA (%) is ranked lower than
56% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.39 vs. CAH: 1.29 )
CAH' s 10-Year ROA (%) Range
Min: 1.29   Max: 10.83
Current: 1.29

1.29
10.83
ROC (Joel Greenblatt) (%) 33.92
CAH's ROC (Joel Greenblatt) (%) is ranked higher than
69% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 34.71 vs. CAH: 33.92 )
CAH' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 13.82   Max: 61.68
Current: 33.92

13.82
61.68
Revenue Growth (%) 2.50
CAH's Revenue Growth (%) is ranked lower than
54% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.60 vs. CAH: 2.50 )
CAH' s 10-Year Revenue Growth (%) Range
Min: 2.5   Max: 22.8
Current: 2.5

2.5
22.8
EBITDA Growth (%) -2.50
CAH's EBITDA Growth (%) is ranked lower than
60% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.10 vs. CAH: -2.50 )
CAH' s 10-Year EBITDA Growth (%) Range
Min: -11.1   Max: 28.9
Current: -2.5

-11.1
28.9
EPS Growth (%) -15.70
CAH's EPS Growth (%) is ranked lower than
55% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.60 vs. CAH: -15.70 )
CAH' s 10-Year EPS Growth (%) Range
Min: -15.8   Max: 31
Current: -15.7

-15.8
31
» CAH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

CAH Guru Trades in Q3 2013

Jim Simons 21,700 sh (New)
Joel Greenblatt 143,906 sh (+772.85%)
Pioneer Investments 1,647,508 sh (+107.35%)
Ray Dalio 75,346 sh (+62.57%)
John Keeley 123,300 sh (+14.72%)
James Barrow 11,518,013 sh (+9.34%)
John Buckingham 17,502 sh (+2.76%)
Manning & Napier Advisors, Inc 30,769 sh (+1.38%)
Vanguard Health Care Fund 8,304,241 sh (unchged)
Paul Tudor Jones Sold Out
John Hussman Sold Out
RS Investment Management 1,178,531 sh (-10.39%)
Jeremy Grantham 426,663 sh (-28.35%)
Steven Cohen 3,896 sh (-96.85%)
David Dreman 2,019 sh (-97.55%)
» More
Q4 2013

CAH Guru Trades in Q4 2013

Caxton Associates 60,901 sh (New)
Paul Tudor Jones 304,200 sh (New)
Steven Cohen 15,860 sh (+307.08%)
Jim Simons 44,000 sh (+102.76%)
Joel Greenblatt 257,325 sh (+78.81%)
John Keeley 164,270 sh (+33.23%)
Pioneer Investments 1,967,912 sh (+19.45%)
John Buckingham 18,267 sh (+4.37%)
David Dreman Sold Out
James Barrow 8,532,117 sh (-25.92%)
RS Investment Management 842,804 sh (-28.49%)
Manning & Napier Advisors, Inc 19,477 sh (-36.7%)
Vanguard Health Care Fund 5,043,241 sh (-39.27%)
Ray Dalio 25,646 sh (-65.96%)
Jeremy Grantham 97,397 sh (-77.17%)
» More
Q1 2014

CAH Guru Trades in Q1 2014

Louis Moore Bacon 6,078 sh (New)
Ray Dalio 48,844 sh (+90.45%)
Joel Greenblatt 379,308 sh (+47.4%)
Steven Cohen 17,553 sh (+10.67%)
Vanguard Health Care Fund 5,043,241 sh (unchged)
Jim Simons Sold Out
John Buckingham 18,131 sh (-0.74%)
Manning & Napier Advisors, Inc 18,931 sh (-2.8%)
Pioneer Investments 1,856,220 sh (-5.68%)
John Keeley 149,817 sh (-8.8%)
Caxton Associates 50,000 sh (-17.9%)
James Barrow 6,958,722 sh (-18.44%)
Paul Tudor Jones 233,468 sh (-23.25%)
Jeremy Grantham 56,000 sh (-42.5%)
RS Investment Management 418,304 sh (-50.37%)
» More
Q2 2014

CAH Guru Trades in Q2 2014

Manning & Napier Advisors, Inc Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with CAH

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
James Barrow 2014-03-31 Reduce -18.44%0.15%$65.26 - $73.54 $ 70.071%6958722
Joel Greenblatt 2014-03-31 Add 47.4%0.13%$65.26 - $73.54 $ 70.071%379308
Ray Dalio 2014-03-31 Add 90.45%0.01%$65.26 - $73.54 $ 70.071%48844
Vanguard Health Care Fund 2013-12-31 Reduce -39.27%0.59%$52.95 - $67.48 $ 70.0714%5043241
James Barrow 2013-12-31 Reduce -25.92%0.25%$52.95 - $67.48 $ 70.0714%8532117
Joel Greenblatt 2013-12-31 Add 78.81%0.18%$52.95 - $67.48 $ 70.0714%257325
John Keeley 2013-12-31 Add 33.23%0.05%$52.95 - $67.48 $ 70.0714%164270
Ray Dalio 2013-12-31 Reduce -65.96%0.02%$52.95 - $67.48 $ 70.0714%25646
David Dreman 2013-12-31 Sold Out 0.01%$52.95 - $67.48 $ 70.0714%0
Joel Greenblatt 2013-09-30 Add 772.85%0.21%$47.02 - $53.57 $ 70.0738%143906
David Dreman 2013-09-30 Reduce -97.55%0.13%$47.02 - $53.57 $ 70.0738%2019
John Hussman 2013-09-30 Sold Out 0.01%$47.02 - $53.57 $ 70.0738%0
Ray Dalio 2013-09-30 Add 62.57%0.01%$47.02 - $53.57 $ 70.0738%75346
James Barrow 2013-06-30 Add 109.21%0.44%$41.85 - $48.76 $ 70.0753%10534000
Joel Greenblatt 2013-06-30 Reduce -64.59%0.06%$41.85 - $48.76 $ 70.0753%16487
Ray Dalio 2013-06-30 Reduce -68.52%0.04%$41.85 - $48.76 $ 70.0753%46346
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Cardinal Health Inc

Weekly CEO Sells Highlight: Cardinal Health, Envision Healthcare Holdings, Tableau Software and Allergan
According to GuruFocus Insider Data, these are the largest CEO sales during the past week: Cardinal Health Inc, Envision Healthcare Holdings Inc, Tableau Software Inc, and Allergan Inc. Read more...
Weekly 52-Week Highs: Toronto-Dominion Bank, Cardinal Health Inc., Marsh & McLennan Companies Inc., Exxon Mobil Corporation and Ameriprise Financial Inc.
According to GuruFocus list of 52-week highs, these Guru stocks have reached their 52-Week Highs: Toronto-Dominion Bank (TD), Cardinal Health Inc. (CAH), Marsh & McLennan Companies Inc. (MMC), Exxon Mobil Corporation (XOM) and Ameriprise Financial Inc. (AMP). Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 71.70
CAH's P/E(ttm) is ranked higher than
50% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 30.20 vs. CAH: 71.70 )
CAH' s 10-Year P/E(ttm) Range
Min: 6.28   Max: 73.63
Current: 71.7

6.28
73.63
P/B 3.70
CAH's P/B is ranked higher than
55% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.36 vs. CAH: 3.70 )
CAH' s 10-Year P/B Range
Min: 0.86   Max: 3.8
Current: 3.7

0.86
3.8
P/S 0.30
CAH's P/S is ranked higher than
87% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.68 vs. CAH: 0.30 )
CAH' s 10-Year P/S Range
Min: 0.08   Max: 0.39
Current: 0.3

0.08
0.39
PFCF 13.10
CAH's PFCF is ranked higher than
91% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 38.56 vs. CAH: 13.10 )
CAH' s 10-Year PFCF Range
Min: 4.3   Max: 32.08
Current: 13.1

4.3
32.08
EV-to-EBIT 23.36
CAH's EV-to-EBIT is ranked higher than
62% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.16 vs. CAH: 23.36 )
CAH' s 10-Year EV-to-EBIT Range
Min: 5.6   Max: 25.5
Current: 23.36

5.6
25.5
PEG 25.90
CAH's PEG is ranked higher than
62% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.08 vs. CAH: 25.90 )
CAH' s 10-Year PEG Range
Min: 0.52   Max: 81.3
Current: 25.9

0.52
81.3
Shiller P/E 26.00
CAH's Shiller P/E is ranked higher than
84% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 81.32 vs. CAH: 26.00 )
CAH' s 10-Year Shiller P/E Range
Min: 5.96   Max: 26.78
Current: 26

5.96
26.78
Current Ratio 1.29
CAH's Current Ratio is ranked higher than
52% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.53 vs. CAH: 1.29 )
CAH' s 10-Year Current Ratio Range
Min: 1.19   Max: 1.83
Current: 1.29

1.19
1.83
Quick Ratio 0.68
CAH's Quick Ratio is ranked lower than
56% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.01 vs. CAH: 0.68 )
CAH' s 10-Year Quick Ratio Range
Min: 0.53   Max: 1.15
Current: 0.68

0.53
1.15

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.80
CAH's Dividend Yield is ranked higher than
56% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.52 vs. CAH: 1.80 )
CAH' s 10-Year Dividend Yield Range
Min: 0.22   Max: 2.66
Current: 1.8

0.22
2.66
Dividend Payout 1.22
CAH's Dividend Payout is ranked higher than
86% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 9999.00 vs. CAH: 1.22 )
CAH' s 10-Year Dividend Payout Range
Min: 0.03   Max: 1.8
Current: 1.22

0.03
1.8
Dividend growth (3y) 14.80
CAH's Dividend growth (3y) is ranked higher than
78% of the 23 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.70 vs. CAH: 14.80 )
CAH' s 10-Year Dividend growth (3y) Range
Min: 10.8   Max: 49.4
Current: 14.8

10.8
49.4
Yield on cost (5-Year) 3.88
CAH's Yield on cost (5-Year) is ranked higher than
67% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.17 vs. CAH: 3.88 )
CAH' s 10-Year Yield on cost (5-Year) Range
Min: 0.47   Max: 5.73
Current: 3.88

0.47
5.73
Share Buyback Rate 1.60
CAH's Share Buyback Rate is ranked higher than
84% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: -0.20 vs. CAH: 1.60 )
CAH' s 10-Year Share Buyback Rate Range
Min: 5.8   Max: -24.2
Current: 1.6

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 25.60
CAH's Price/Tangible Book is ranked higher than
54% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 7.98 vs. CAH: 25.60 )
CAH' s 10-Year Price/Tangible Book Range
Min: 1.21   Max: 53.03
Current: 25.6

1.21
53.03
Price/DCF (Projected) 1.30
CAH's Price/DCF (Projected) is ranked higher than
80% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.63 vs. CAH: 1.30 )
CAH' s 10-Year Price/DCF (Projected) Range
Min: 0.31   Max: 5.4
Current: 1.3

0.31
5.4
Price/Median PS Value 1.50
CAH's Price/Median PS Value is ranked higher than
55% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.29 vs. CAH: 1.50 )
CAH' s 10-Year Price/Median PS Value Range
Min: 0.49   Max: 3.92
Current: 1.5

0.49
3.92
Price/Graham Number 8.90
CAH's Price/Graham Number is ranked higher than
54% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.27 vs. CAH: 8.90 )
CAH' s 10-Year Price/Graham Number Range
Min: 0.75   Max: 10.63
Current: 8.9

0.75
10.63
Earnings Yield (Greenblatt) 4.30
CAH's Earnings Yield (Greenblatt) is ranked higher than
57% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.10 vs. CAH: 4.30 )
CAH' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.9   Max: 17.9
Current: 4.3

3.9
17.9
Forward Rate of Return (Yacktman) 7.39
CAH's Forward Rate of Return (Yacktman) is ranked higher than
57% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.14 vs. CAH: 7.39 )
CAH' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 4.9   Max: 21.4
Current: 7.39

4.9
21.4

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:ABC, MCK, SHTDF, HSIC, PDCO » details
Traded in other countries:CLH.Germany
Cardinal Health, Inc is an Ohio corporation formed in 1979. It is a healthcare services company providing pharmaceutical and medical products and services that help pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers focus on patient care while reducing costs, enhancing efficiency and improving quality. Cardinal Health, Inc. also provides medical products to patients in the home. The Company has two operating segments: Pharmaceutical and Medical. The Pharmaceutical segment recognizes distribution revenue when title transfers to its customers and the Company have further obligation to provide services related to such merchandise. Radiopharmaceutical revenue is recognized upon delivery of the product to the customer and the Company has no further obligation to provide services related to such merchandise. The Medical segment recognizes revenue when title transfers to its customers and the Company have no further obligation to provide services related to such merchandise. In the Pharmaceutical segment, it competes with wholesale distributors with national reach (including McKesson Corporation, AmerisourceBergen Corporation and H.D. Smith. In the Medical segment, it compete with many different distributors, including Owens & Minor, Inc., Thermo Fisher Scientific Inc., McKesson Corporation, Henry Schein, Inc., Medline Industries, Inc., Mediq NV (through Byram Healthcare) and CCS Medical Holdings, Inc. . The Company's operations are affected by federal, state and local environmental laws.
» More Articles for CAH

Headlines

Articles On GuruFocus.com
Top Insider Sells Highlight: Cardinal Health Inc. Jul 17 2014 
Cardinal Health Inc. (CAH) Dividend Stock Analysis Jul 03 2014 
8 Dividend Stocks with a 15% Yield in 15 Years May 14 2014 
7 Stocks Building Shareholder Returns with Higher Dividends May 12 2014 
CR Bard Focuses on Small to Medium-Sized Deals Apr 04 2014 
Weekly CEO Sells Highlight: Cardinal Health, Envision Healthcare Holdings, Tableau Software and Alle Feb 16 2014 
Weekly CFO Sells Highlight: Facebook Inc., Cardinal Health Inc., Alexion Pharmaceuticals Inc., Therm Feb 10 2014 
Cardinal Health Inc. Dividend Stock Analysis Dec 13 2013 
6 Health Care Stocks with Growing Dividends Yielding in Excess of 2% Oct 09 2013 
4 Good Looking Dividend Stocks with High Beta Ratios from the Services Sector Aug 08 2013 

More From Other Websites
Venture Capital-Backed M&A Deal Value Falls In Q2 Jul 14 2014
[video] Akers CEO: We Are Growing Globally and Now Is the Time for Investors to Take Notice Jul 10 2014
Cardinal Health Supports Future Pharmacists with $2 Million in Scholarships Jul 07 2014
Cardinal Health Supports Future Pharmacists with $2 Million in Scholarships Jul 07 2014
Midday movers: Lorillard, PetSmart, Walgreen & More Jul 03 2014
DRIVING THE FUTURE: 7 Lessons the Medical Device Supply Chain Can Learn from the Auto Industry Jul 01 2014
Cardinal Health To Release Fourth-Quarter And Full-Year Results For Fiscal Year 2014 On Aug. 4 Jul 01 2014
Cardinal Health To Release Fourth-Quarter And Full-Year Results For Fiscal Year 2014 On Aug. 4 Jul 01 2014
I Have No Fear Of A Market Crash Or A Significant Correction, Here's Why: Part 1 Jun 13 2014
Cardinal Health (CAH) Showing Signs Of Being Water-Logged And Getting Wetter Jun 12 2014
Cardinal Health Statement on the Death of Glenn A. Britt Jun 12 2014
[$$] Cardinal Health Finance Chief Sets Retirement Jun 11 2014
CARDINAL HEALTH INC Files SEC form 8-K, Change in Directors or Principal Officers Jun 11 2014
Cardinal Health CFO Jeffrey Henderson To Retire At End Of Fiscal Year 2015 Jun 11 2014
Cardinal Health Launches Medication Therapy Management Solution to Make it Easier for Retail... Jun 04 2014
Key Factors to Consider When Choosing an Effective HEOR Analytics Partner May 30 2014
Analyst Stocks to Buy for an Aging America May 30 2014
Exclusive - U.S. companies seek cyber experts for top jobs, board seats May 30 2014
Nine Companies with the Most Unusual Origins May 27 2014
New Studies Show Cardinal Health Specialty Solutions' Clinical Pathways Improve Cost Effectiveness... May 27 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide